New plate-based multiplexing unlocks ultra-high-sample and cell-throughput single cell analysis to empower a broad range of studies.

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Stanford researchers have created a device that uses electromagnetic levitation to gently sort cells by type. The cells are ...

New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of ...

How do the circuits of the human brain work—and what happens when they are disrupted? To investigate these questions, ...

On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...

According to a filing with the Securities and Exchange Commission dated October 8, 2025, Lancaster Investment Management ...

Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026 ...

Cell and gene therapies promise one-dose cures and drive South Korea biotech growth South Korea positions itself as a hub for ...

On October 23 REPT BATTERO unveiled comprehensive strategic new products at its inaugural Brand Day, across its three major ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...